questionText: To ask the Secretary of State for Health and Social Care, what funding his Department has allocated for emerging Duchenne muscular dystrophy treatments; and what plans he has to ensure that future therapies, including gene therapies and exon-skipping treatments, are assessed and funded through the NHS in a timely manner for patients who do not benefit from currently approved treatments.
answerText: The Department understands the impact that Duchenne muscular dystrophy has on those living with it and their families, and the urgent need for new treatment options. The Department has not allocated any funding specifically for emerging treatments for Duc...
heading: Muscular Dystrophy: Medical Treatments